RK Capital - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
RK Capital ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$12,835,000
+54.9%
94,583
+213.4%
3.64%
+94.6%
Q3 2018$8,285,000
-21.7%
30,183
-40.9%
1.87%
-19.8%
Q2 2018$10,583,000
+33.0%
51,083
+6.0%
2.33%
+35.1%
Q1 2018$7,958,000
+49.8%
48,183
+24.2%
1.73%
+54.7%
Q4 2017$5,311,000
-53.9%
38,783
-54.2%
1.12%
-58.4%
Q3 2017$11,530,000
-45.9%
84,683
-51.8%
2.69%
-37.4%
Q2 2017$21,328,000
+11.7%
175,683
-2.7%
4.29%
+16.1%
Q1 2017$19,102,000
-2.0%
180,483
-5.9%
3.70%
-8.4%
Q4 2016$19,497,000
+5.3%
191,883
+5.8%
4.04%
+12.3%
Q3 2016$18,512,000
+26.2%
181,383
+47.5%
3.59%
+37.4%
Q2 2016$14,668,000
-9.8%
122,983
-19.0%
2.62%
-2.8%
Q1 2016$16,254,000
+17.1%
151,783
+18.6%
2.69%
+11.1%
Q4 2015$13,876,000
+86.9%
127,983
+47.6%
2.42%
+78.3%
Q3 2015$7,424,000
+119.8%
86,683
+158.9%
1.36%
+122.4%
Q2 2015$3,378,000
-38.5%
33,483
-53.0%
0.61%
-44.2%
Q1 2015$5,497,000
-49.0%
71,283
-64.8%
1.10%
-48.7%
Q4 2014$10,779,000
+31.6%
202,583
+16.2%
2.13%
+27.4%
Q3 2014$8,190,000
+5.7%
174,283
+40.2%
1.67%
+8.4%
Q2 2014$7,745,000
+18.9%
124,334
+28.4%
1.54%
+16.9%
Q1 2014$6,514,000
-8.5%
96,834
-28.4%
1.32%
-24.4%
Q4 2013$7,119,000
+65.1%
135,334
+35.8%
1.75%
+42.1%
Q3 2013$4,313,00099,6431.23%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders